Article: De Novo Pharmaceuticals Ltd and ChemOvation Ltd Announce Drug Research Collaboration.

CAMBRIDGE, UK, Oct. 31 /PRNewswire/ --

De Novo Pharmaceuticals Ltd (De Novo) and ChemOvation Ltd are pleased to announce that they have entered into a collaborative agreement for the provision of synthetic chemistry services directed towards certain De Novo drug discovery targets. Under the terms of the collaboration, full details of which have not been disclosed, ChemOvation will provide synthetic chemistry services and expertise for the generation of low molecular weight drug like compounds arising from De Novo's proprietary computational modelling for a number of targets currently within De Novo's discovery portfolio.

Dr Alan Stuttle, Chief Executive ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!